Grove Biopharma is a preclinical biotechnology startup, pioneering the discovery and development of a new drug modality to access challenging therapeutic targets. Our Precision-Linked Proteomimetic™ platform has the potential to address significant unmet medical needs in oncology, neurodegenerative disease, and other rare diseases.